[Transcatheter mitral valve-in-valve implantation (TMViVI)]

Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
Record ID 32015000949
German
Authors' objectives: The transcatheter mitral valve-in-valve implantation (TMViVI) is a technology that is primarily used for elderly people with a failing mitral prosthesis. In addition, these patients usually have several co-morbidities. The valve-invalve concept has been so far primarily used for aortic valve replacement. However, since 2009 a small number of case reports has been published and there are a few, small-sized case series reporting about valve-in-valve applications for the replacement of dysfunctioning mitral valves. In Europe, the products of Edwards Lifesciences, Inc. (USA) are availbale for TMViVI. The aim of this systematic review is to evaluate the efficacy and safety of TMViVI compared to the standard surgical therapy, or no intervention
Authors' recommendations: The health technology is at an early stage of research. The results of 83 patients have so far been published worldwide. However, there is a research need for controlled trials. Patient-relevant benefits cannot be assessed adequately on the basis of the available studies. Currently, the inclusion into the hospital benefit catalogue is not recommended. A re-evaluation is proposed in 2017.
Details
Project Status: Completed
URL for project: http://hta.lbg.ac.at/page/bewertung-medizinischer-einzelleistungen-mel-2015
Year Published: 2015
URL for published report: http://eprints.hta.lbg.ac.at/1058/1/DSD_82.pdf
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Austria
MeSH Terms
  • Bioprosthesis
  • Cardiac Catheterization
  • Heart Valve Prosthesis Implantation
  • Mitral Valve Insufficiency
  • Mitral Valve Stenosis
Contact
Organisation Name: Ludwig Boltzmann Institute for Health Technology Assessment
Contact Address: Ludwig Boltzmann Institute for fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7/rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99
Contact Name: tarquin.mittermayr@aihta.at
Contact Email: office@aihta.at
Copyright: Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.